Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology... Show more
HSIC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where HSIC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HSIC's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where HSIC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on HSIC as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HSIC just turned positive on April 22, 2025. Looking at past instances where HSIC's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HSIC advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 50-day moving average for HSIC moved below the 200-day moving average on April 21, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSIC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for HSIC entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HSIC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.611) is normal, around the industry mean (7.892). P/E Ratio (23.503) is within average values for comparable stocks, (29.460). Projected Growth (PEG Ratio) (1.727) is also within normal values, averaging (4.521). HSIC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (0.793) is also within normal values, averaging (35.215).
a distributer of healthcare products and services
Industry MedicalDistributors
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LSGR | 33.69 | 0.87 | +2.65% |
Natixis Loomis Sayles Focused Growth ETF | |||
USPX | 47.03 | 0.81 | +1.75% |
Franklin US Equity Index ETF | |||
APRH | 24.05 | 0.20 | +0.85% |
Innovator Premium Income 20 Bar ETF -Apr | |||
FBND | 45.04 | 0.11 | +0.24% |
Fidelity Total Bond ETF | |||
GMOM | 28.48 | -0.05 | -0.17% |
Cambria Global Momentum ETF |
A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.
Ticker / NAME | Correlation To HSIC | 1D Price Change % | ||
---|---|---|---|---|
HSIC | 100% | +1.47% | ||
ZYXI - HSIC | 24% Poorly correlated | +7.96% | ||
CAH - HSIC | 20% Poorly correlated | +0.55% | ||
OMI - HSIC | 19% Poorly correlated | +2.78% | ||
COR - HSIC | 18% Poorly correlated | -0.54% | ||
SHTDY - HSIC | 11% Poorly correlated | -3.51% | ||
More |